Symptoms of COPD Patients With A History of Smoking and Non-Smoking
Keywords:
COPD, Dyspnea, SymptomAbstract
Background: Chronic Obstructive Pulmonary Disease (COPD) is a progressive, incurable lung disease that causes chronic respiratory difficulty. Smoking is the primary risk factor for COPD, while some patients with the disease have never smoked. Understanding the differences in symptoms between patients with and without a smoking history can help guide more effective intervention.
Purpose: The purpose of this study is to identify and compare COPD symptom reports in patients with and without smoking history.
Methods: This study used a descriptive method with secondary data from COPD patients divided into two groups: those with a history of smoking (n=20) and those who did not smoke (n=20). Symptom complaints were classified into three types: good (3), sufficient (2), and poor (1). The percentage of each category was calculated to describe how the symptom reports were distributed throughout each group.
Results: In the group of COPD patients with a smoking history, 6 patients (30%) reported good symptoms, while 14 patients (70% reported sufficient symptoms). In the group without a smoking history, 14 patients reported good symptoms (70%), while 6 patients had sufficient symptoms (30%). In both groups, no patients reported problems that were rated insufficient. These findings suggest that patients with a history of smoking are more probable to suffer symptoms at a sufficient level than those without a history of smoking.
Conclusion: There is a difference in the distribution of COPD symptom reports between those with and without a smoking history, with those who have smoked having moderate symptoms. This study emphasizes the importance of stopping smoking in reducing the severity of symptoms in COPD patients.
References
Adeloye, D., et al. (2022). The impact of smoking on the quality of life of COPD patients: A meta-analysis. *European Respiratory Journal*, 59(3), pp.1105–1111.
Agusti, A., et al. (2021). Management of COPD and the role of patient-specific treatment plans. *Journal of Respiratory Diseases*, 34(6), pp.523–534.
Arslan, Z., et al. (2022). Environmental pollutants and non-smoking COPD: Assessing risk and prevalence. *Journal of Respiratory Health*, 14(3), pp.205–214. https://doi.org/10.1016/j.jresphe.2022.03.012
Barnes, P.J. (2021). Smoking-related lung damage and its effects on COPD symptoms. *The Lancet Respiratory Medicine*, 9(10), pp.1092–1094.
Bernatsky, S., et al. (2021). Smoking duration and COPD prevalence: A meta-analysis of population studies. *Pulmonary Medicine Review*, 29(1), pp.45–54. https://doi.org/10.1016/j.pulmmed.2021.01.008
Chen, R., et al. (2020). COPD in non-smokers: Clinical outcomes and disease progression. *Respiratory Research*, 21(1), p.128.
Collaborators, GBD 2019 Diseases and Injuries (2020). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2019. *The Lancet*, 392(10159), pp.1736–1788. https://doi.org/10.1016/S0140-6736(19)32319-0
Criner, G.J., et al. (2021). Current treatment strategies for COPD exacerbations and their outcomes. *Respiratory Medicine*, 179, p.106328. https://doi.org/10.1016/j.rmed.2021.106328
Donaldson, G.C., et al. (2020). Frequency of exacerbations in COPD: A longitudinal study of COPD patients in primary care. *Thorax*, 75(2), pp.101–107. https://doi.org/10.1136/thoraxjnl-2019-213682
Fabbri, L.M. & Rabe, K.F. (2022). Tailored COPD therapies based on patient phenotypes. *European Respiratory Journal*, 60(4), p.2101409. https://doi.org/10.1183/13993003.01409-2022
Fabbri, L.M. & Rabe, K.F. (2023). Future directions in COPD research: Exploring symptom management in diverse patient populations. *Journal of Thoracic Disease*, 15(2), pp.115–125.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2023). Global strategy for the diagnosis, management, and prevention of COPD. Available at: https://goldcopd.org
Hurst, J.R., et al. (2019). Symptoms and exacerbation risk in smokers and former smokers with COPD. *Chest*, 156(3), pp.558–567. https://doi.org/10.1016/j.chest.2019.05.022
Jin, J., et al. (2019). Smoking cessation and COPD management: An evidence-based approach. *Pulmonary Pharmacology & Therapeutics*, 55, pp.105–115. https://doi.org/10.1016/j.pupt.2019.05.001
Lee, C. & Park, H. (2022). A comparative study of COPD symptom severity between smokers and non-smokers. *BMC Pulmonary Medicine*, 22(1), p.114.
Salvi, S. & Barnes, P.J. (2021). Is exposure to biomass smoke the biggest risk factor for COPD globally? *Chest*, 160(6), pp.2063–2072. https://doi.org/10.1016/j.chest.2021.07.021
Soriano, J.B., et al. (2022). Prevalence and distribution of COPD in non-smoking populations. *Respiratory Research*, 23(1), p.45. https://doi.org/10.1186/s12931-022-01952-1
Sundar, I.K. & Rahman, I. (2020). Role of cigarette smoke–induced oxidative stress in chronic obstructive pulmonary disease. *Free Radical Biology and Medicine*, 152, pp.130–143. https://doi.org/10.1016/j.freeradbiomed.2020.03.026
Tashkin, D.P. & Murray, R.P. (2020). Smoking cessation in COPD: Benefits and management strategies. *Chest*, 158(5), pp.1600–1610.
Vestbo, J., et al. (2022). COPD exacerbations and symptoms: Insights from longitudinal studies. *The Lancet Respiratory Medicine*, 10(2), pp.123–133. https://doi.org/10.1016/S2213-2600(21)00464-6
Wang, L., et al. (2021). The impact of smoking cessation on COPD progression and symptoms. *International Journal of Chronic Obstructive Pulmonary Disease*, 16, pp.1883–1891.
World Health Organization (2022). Chronic obstructive pulmonary disease (COPD) fact sheet. Available at: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
